دوره 2، شماره 1 - ( 10-1386 )                   جلد 2 شماره 1 صفحات 54-59 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Noroozi A, Mianji F. Singapore's Experience With Buprenorphine (Subutex). IJPBS. 2008; 2 (1) :54-59
URL: http://ijpbs.mazums.ac.ir/article-1-132-fa.html
Singapore's Experience With Buprenorphine (Subutex). Iranian Journal of Psychiatry and Behavioral Sciences. 1386; 2 (1) :54-59

URL: http://ijpbs.mazums.ac.ir/article-1-132-fa.html


چکیده:   (8887 مشاهده)
Buprenorphine (Subutex) has been used to treat opioid dependency in the past 16 years. Subutex (or buprenorphine hydrochloride) was approved by the Singapore's Ministry of Health (MOH) in 2000 as a substitution treatment for opiate-dependent drug abusers within the framework of medical, social and psychological treatments. It was subsequently introduced into the Singapore market in 2002. In spite of the promise of improvement in the lives of addicts with medical care, a distinct trend of buprenorphine abuse has occurred. A cascade of events from 2002 to 2006 led to discontinuation of Subutex treatment programs in the country. In this paper, firstly reports on morbidity and mortality caused by Subutex IV abuse will be reviewed and secondly, the MOH response to the situation will be outlined and finally, implications of Singapore’s experience with Subutex will be discussed.
متن کامل [PDF 241 kb]   (1154 دریافت)    
نوع مطالعه: پژوهشي | موضوع مقاله: روانپزشکی
دریافت: ۱۳۹۱/۳/۸ | پذیرش: ۱۳۹۲/۱۰/۱۶ | انتشار: ۱۳۹۲/۱۰/۱۶

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
کد امنیتی را در کادر بنویسید

کلیه حقوق این وب سایت متعلق به Iranian Journal of Psychiatry and Behavioral Sciences می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2015 All Rights Reserved | Iranian Journal of Psychiatry and Behavioral Sciences

Designed & Developed by : Yektaweb